← All Sponsors
SPONSOR

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: ObeseObesityObesity Type 2 Diabetes MellitusWeight Loss
NCT07400588 Phase 2
Recruiting

Aleniglipron Phase 2 in Type 2 Diabetes Mellitus

Obese
United States View Trial →